5. TREATMENT
โข Surgery
โข Systemic therapy
โข Radiotherapy
SURGERY
SYSTEMIC
THERAPY
GASTRIC
CANCER
RADIO
THERAPY
Cornerstone - Surgery
Prof. S. Subbiah et al
14. Endoscopic Resection Vs Gastrectomy
Wang et al-
Meta analysis
โข No difference in OS
โข Shorter hospital stay and
reduced perioperative
morbidity with ER
Prof. S. Subbiah et al
16. Endoscopic Resection - Curability
UL - Ulceration
SM 1 - <500microns
from m.mucosa
VM - Vertical margin
HM - Horizontal margin
LyV - Lymphovascular
invasion
Prof. S. Subbiah et al
17. T1a - Surgery
โข Tumors that do not meet the criteria for EMR/ESD
โข Proximal or Pylorus preserving Gastrectomy
โข D1 lymphadenectomy
โข No role for nodal sampling or SLN Mapping
Prof. S. Subbiah et al
18. T1a - Surgery
Proximal Gastrectomy Pylorus preserving Gastrectomy
Prof. S. Subbiah et al
19. T1a - Surgery
Local Resection Segmental Gastrectomy
Non Standard Treatment
( Investigational )
Prof. S. Subbiah et al
21. T1b
โข Gastrectomy โ depending upon the tumor site
โข D1 Lymphadenectomy โ
Differentiated type &
1.5 cm or smaller
โข D1+ lymphadenectomy โ all other T1b tumors
Prof. S. Subbiah et al
26. Criteria of Unresectability
โข Locoregionally advanced
o Disease infiltration of the root of the mesentery
o Para-aortic lymph node highly suspicious on imaging or confirmed by biopsy
o Invasion or encasement of major vascular structures
(excluding the splenic vessels)
โข Distant metastasis or peritoneal seeding (including positive peritoneal cytology)
Prof. S. Subbiah et al
27. Locoregional cancer โ T2 and above, any N
Medically fit and potentially resectable
Loco regional
โข Surgery or Periop Chemo or Preop ChemoRT
Medically fit and unresectable
Loco regional
โข Chemoradiation or Systemic therapy
Non surgical candidates
Loco regional
โข Palliative/Best supportive care
Prof. S. Subbiah et al
28. Staging Laparoscopy and Peritoneal cytology
โข Staging laparoscopy should be done before surgery, as CT cannot detect
peritoneal metastasis with <5mm size.
โข Unnecessary laparotomies can be avoided in 38% (Muntean et al)
โข It allows assessment of peritoneal cytology and laparoscopic ultrasound
โข NCCN recommends diagnostic laparoscopy for patients with resectable stage
cT1b or higher locoregional disease
Prof. S. Subbiah et al
29. Surgery for Locoregional Cancer
โข Gastric Resection
โข Lymphadenectomy
โข Reconstruction
Prof. S. Subbiah et al
30. Surgery for Locoregional Cancer
Standard
Gastrectomy
Total Gastrectomy
D2
lymphadenectomy
Subtotal
Gastrectomy
D2
lymphadenectomy
Non Standard
Gastrectomy
Multi organ
resection
Extended
lymphadenectomy
Prof. S. Subbiah et al
32. Margin
๏ง PROXIMAL MARGIN
โข T1 tumours - 2cm
โข T2 or deeper - 3cm for expansive growth pattern (type 1 & 2)
5cm for infiltrative growth pattern (type 3 & 4)
๏ง DISTAL MARGIN
Distal to pylorus
Subtotal Gastrectomy is done when a satisfactory proximal resection margin can
be obtained
Prof. S. Subbiah et al
33. Total Vs Subtotal Gastrectomy
Angelov et al โ Comparable oncological outcome
Prof. S. Subbiah et al
35. Lymphadenectomy - East
โข D2 for cN+ or โฅ cT2
โข D2 lymphadenectomy should be performed whenever the
possibility of nodal involvement cannot be dismissed.
Prof. S. Subbiah et al
37. D2+ Lymphadenectomy
โข Dissection of No. 10 with or without splenectomy
โข Dissection of No. 13 for cancer invading the duodenum
Prof. S. Subbiah et al
38. Para aortic node dissection (PAND)
โข Bulky D1 or D2 nodes
โข Para aortic node + disease without other unresectable factors โ
Neoadjuvant therapy followed by D2 lymphadenectomy and PAND
โข Routine PAND ?
No survival advantage
Prof. S. Subbiah et al
39. Lymphadenectomy - West
โข Gastrectomy with a D1 or a modified D2 lymph node dissection, with a goal of
examining 16 or more lymph nodes
โข D2 lymph node dissections should be performed by experienced surgeons in
high-volume centers
โข Trials
๏ง Dutch Gastric cancer group trial
๏ง Medical Research council (MRC) Trial -UK
๏ง Italian Gastric cancer study group
Prof. S. Subbiah et al
42. Splenectomy
Routine splenectomy is not indicated unless the spleen is involved
or extensive hilar adenopathy is noted
Prof. S. Subbiah et al
43. West meets East โ D2 lymphadenectomy
Prof. S. Subbiah et al
44. Minimally Invasive surgery
โข Non inferiority in terms of oncological outcomes
โข Early Gastric Cancer vs Locally advanced GC
โข KLASS-01 trial and JCOG 0703
โข KLASS-02 trial
Prof. S. Subbiah et al
45. Minimally Invasive surgery
Trials revealed similar overall and
cancer-specific survival rates
between patients receiving
laparoscopic and open distal
gastrectomy in EGC
Prof. S. Subbiah et al
46. Minimally Invasive Surgery
โข Locally advanced cancer โ Non inferiority trial
โข 3 Year DFS โ Comparable
โข Could be a potential standard treatment option for LAGC
Prof. S. Subbiah et al
52. SEMS VS GJ
โข Patients with acceptable PS should be primarily considered for a
palliative GJ rather than stenting
โข Life expectancy > 2 months โ GJ preferable
Prof. S. Subbiah et al
53. Take home message
โข Endoscopic resection vs Surgery
โข Total Vs subtotal Gastrectomy
โข Lymphadenectomy D2 vs D1
โข SLNB
โข Bursectomy
โข Splenectomy
โข Multiorgan resection
โข PAND
โข Lap Vs open Surgery
โข Reconstruction - Pouch
โข Palliative surgery โ GJ vs SEMS
Prof. S. Subbiah et al
These are the derivatives of ventral and dorsal mesogastrium and carry the principal blood vessels of the stomach. Knowledge of these ligaments is necessary for us to identify and ligate these vessels at their origin
From there we have moved on to the concept of lymph nodal stations. Where the west were recommending to go by the number of nodes, the eastern concept was centered around the location of metastasis.
The japanese research society classified the nodes around the stomach as regional nodes or N1 nodes, other regional or N2 nodes, distant or N3 nodes. These distant nodes were still not considered to be metastatic ones
Ct cannot identify low volume peritoneal microscopic metastasis that are <5mm in size